Company Filing History:
Years Active: 1992
Title: The Innovations of Christopher C Hentschel
Introduction
Christopher C Hentschel is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work has implications for various applications, including immunology and protein purification.
Latest Patents
Hentschel holds a patent for a C-terminal CAT fusion protein and the process of its preparation by recombinant methods. This innovative process involves the production of a fusion protein that includes an active portion of a chloramphenicol acetyltransferase (CAT) protein combined with a polypeptide. The fusion protein can be purified using CAT substrate affinity chromatography, making it a valuable tool in biotechnological applications. The polypeptides described in his patent include calcitonin and its derivatives, as well as various enzymes and hormones. The fusion protein can also be cleaved to produce free polypeptides, which can be utilized as immunogens.
Career Highlights
Hentschel is associated with Celltech Limited, a company known for its advancements in biopharmaceuticals. His work at Celltech has allowed him to explore innovative solutions in protein engineering and therapeutic development.
Collaborations
Some of his notable coworkers include Alan D Bennett and Stephen Keith Rhind. Their collaborative efforts have contributed to the success of various projects within the company.
Conclusion
Christopher C Hentschel's contributions to the field of biotechnology through his innovative patent and work at Celltech Limited highlight his role as a significant inventor. His advancements in fusion protein technology continue to influence the industry.